EFFECT OF A RESERPINE-LIKE AGENT ON THE RELEASE AND METABOLISM OF [H-3] NA IN CELL-BODIES AND TERMINALS

被引:3
作者
FILINGER, EJ [1 ]
机构
[1] UNIV BUENOS AIRES,FAC FARM & BIOQUIM,RA-1113 BUENOS AIRES,ARGENTINA
来源
GENERAL PHARMACOLOGY | 1994年 / 25卷 / 05期
关键词
CAT SUPERIOR CERVICAL GANGLION; CAT NICTITATING MEMBRANE; RO4-1284; RESERPINE-LIKE AGENT; NORADRENALINE METABOLISM;
D O I
10.1016/0306-3623(94)90116-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The reserpine-like agent, Ro4-1284 (2-hydroxy-2ethyl-3-isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11b-[H]benzo (a)quinolizine) releases [H-3]noradrenaline ([H-3]NA) from prelabelled superior cervical ganglion (cell bodies) and nictitating membrane (nerve endings) of the cat. 2. The potency of Ro4-1284 29.0 mu M was higher in the cell bodies than in the nerve endings. 3. In both tissues, exposure to the reserpine-like agent Ro4-1284 induced a selective increase in the spontaneous outflow of [H-3]DOPEG, while the [H-3]OMDA metabolites to the release induced by Ro4-1284 was very small. 4. The desamination is the preferential way of the metabolic inactivation of the [H-3]NA released by the reserpine-like agent in both parts of the noradrenergic neuron.
引用
收藏
页码:1039 / 1043
页数:5
相关论文
共 14 条
[1]  
ADLERGRA.E, 1972, J PHARMACOL EXP THER, V180, P286
[2]  
BRODIE BB, 1966, J PHARMACOL EXP THER, V154, P493
[3]   POSSIBLE PHYSIOLOGICAL SIGNIFICANCE OF INITIAL STEP IN CATABOLISM OF NORADRENALINE IN CENTRAL NERVOUS-SYSTEM OF RAT [J].
FARAH, MB ;
ADLERGRASCHINSKY, E ;
LANGER, SZ .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1977, 297 (02) :119-131
[4]  
FILINGER E J, 1981, Acta Physiologica Latinoamericana, V31, P105
[5]   MAO-A AND MAO-B IN THE SUPERIOR CERVICAL-GANGLION AND IN THE NICTITATING-MEMBRANE OF THE CAT [J].
FILINGER, EJ ;
STEFANO, FJE .
GENERAL PHARMACOLOGY, 1981, 12 (06) :481-484
[6]  
FISCHER JE, 1965, J PHARMACOL EXP THER, V224, P401
[7]   PREFERENTIAL METABOLISM OF (-)-H-3-NOREPINEPHRINE THROUGH DEAMINATED GLYCOL IN RAT VAS-DEFERENS [J].
GRAEFE, KH ;
STEFANO, FJE ;
LANGER, SZ .
BIOCHEMICAL PHARMACOLOGY, 1973, 22 (10) :1147-1160
[8]  
KOPIN IJ, 1964, PHARMACOL REV, V16, P179
[9]  
KOPIN IJ, 1962, J PHARMACOL EXP THER, V138, P351
[10]  
LANGER SZ, 1974, MED BIOL, V52, P372